Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2020-08-01
2021-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims at following urine pH progression at the time of diagnosis of UTI and during the treatment phase.
Description of the change in urine pH over time will help understanding the risk of struvite formation and potential timing of intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Impact on Urinary pH in Women With Interstitial Cystitis
NCT03041194
Interstitial Cystitis and Urinary pH
NCT03024619
Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction
NCT04937712
Can Consumption of an Aronia-mixture Prevent Urinary Tract Infections in Female Patients?
NCT06618768
Bladder Environment: Microbiome Oxygen Relationship
NCT02868463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cystitis
Patients with lower UTI will be included in this group
No interventions assigned to this group
Pyelonephritis
Patients with higher UTI will be included in this group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* urine-stix positive for leucocytes OR positive culture (\>10E5 cfu/ml)
Group 2. Pyelonephritis
* Unilateral flank pain, pollakiuria, dysuria, fever (\>38.5°C) AND
* urine-stix positive for leucocytes OR positive culture (\>10E5 cfu/ml)
Exclusion Criteria
* Presence of a urine catheter
* Sepsis - septic shock
* Patient taking drug interfering with urine pH (diuretics, citrate, acetazolamide, topiramate,...)
* Patients with UTI diagnosed in the preceding month
* Patients having received antibiotics during the preceding month
* Male patient with a diagnosis of prostatitis
* Presence of infected kidney cyst
* Patient with diabetes
* Pregnant female
* Patient with obstructive pyelonephritis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Vaudois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Bonny
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Bonny, MD-PhD
Role: PRINCIPAL_INVESTIGATOR
CHUV-Lausanne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UniSanté
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-00779
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.